Medicare Enrolled

Dr. Julie Schwartzbard, MD

Neurology · Aventura, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
21000 NE 28TH AVE STE 205, Aventura, FL 33180
3059335993
Registered in NPPES since 2005
NPI: 1578558821 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schwartzbard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwartzbard? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schwartzbard

Dr. Julie Schwartzbard is a neurology specialist in Aventura, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Schwartzbard performed 268 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Schwartzbard received a total of $472,713 from 66 pharmaceutical and/or device companies across 1187 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schwartzbard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ 268 Medicare services $472,713 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 72444 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
268
Medicare services
Bottom 31% in FL for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
206 $103 $562
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $71 $397
Balance testing with recording
A procedure to evaluate balance function by recording the results during testing.
11 $90 $465
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$472,713
Total received (2018-2024)
Avg $67,530/year across 7 years
Top 2% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,187
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$49,502
2023
$86,474
2022
$58,905
2021
$70,173
2020
$71,865
2019
$81,585
2018
$54,209

Payments by company (2024)

Eisai Inc.
$42,782
Eli Lilly and Company
$4,200
Amneal Pharmaceuticals LLC
$1,280
Lilly USA, LLC
$626
ABBVIE INC.
$204
PFIZER INC.
$94
GE HEALTHCARE
$88
Neurocrine Biosciences, Inc.
$62
Novartis Pharmaceuticals Corporation
$53
Otsuka America Pharmaceutical, Inc.
$25
LivaNova USA, Inc.
$23
ACADIA Pharmaceuticals Inc
$19
Amgen Inc.
$16
Alexion Pharmaceuticals, Inc.
$15
Celgene Corporation
$15
Top 3 companies account for 97.5% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$128,485
Eisai Inc.
$108,809
Acorda Therapeutics, Inc
$43,873
Adamas Pharmaceuticals, Inc.
$28,640
Avanir Pharmaceuticals, Inc.
$26,684
Neurocrine Biosciences, Inc.
$26,663
Amneal Pharmaceuticals LLC
$18,679
AbbVie Inc.
$15,631
ACADIA Pharmaceuticals Inc
$14,657
Eli Lilly and Company
$13,313
Biohaven Pharmaceuticals, Inc.
$13,069
ABBVIE INC.
$9,747
Kyowa Kirin, Inc.
$5,686
Allergan, Inc.
$5,343
Neurocrine BioSciences, Inc.
$2,250
EISAI INC.
$1,775
Allergan Inc.
$1,109
UCB, Inc.
$963
Biohaven Pharmaceutical Holding Company Ltd.
$864
Novartis Pharmaceuticals Corporation
$716
Teva Pharmaceuticals USA, Inc.
$521
Biogen, Inc.
$454
Sunovion Pharmaceuticals Inc.
$359
GENZYME CORPORATION
$341
Amgen Inc.
$335
Alexion Pharmaceuticals, Inc.
$321
EMD Serono, Inc.
$309
Lundbeck LLC
$289
SK Life Science, Inc.
$247
PFIZER INC.
$235
US WorldMeds, LLC
$234
Boston Scientific Corporation
$190
Janssen Pharmaceuticals, Inc
$160
Mitsubishi Tanabe Pharma America, Inc.
$149
Supernus Pharmaceuticals, Inc.
$146
Upsher-Smith Laboratories LLC
$145
GE HEALTHCARE
$135
GE HealthCare
$92
Genentech USA, Inc.
$87
ARGENX US, INC.
$67
Greenwich Biosciences, Inc.
$67
MITSUBISHI TANABE PHARMA AMERICA, INC.
$67
UPSHER-SMITH LABORATORIES LLC
$62
Horizon Therapeutics plc
$56
E.R. Squibb & Sons, L.L.C.
$53
Promius Pharma LLC
$52
Abbott Laboratories
$51
Grifols USA, LLC
$49
Impax Laboratories, Inc.
$45
Otsuka America Pharmaceutical, Inc.
$44
LivaNova USA, Inc.
$43
Currax Pharmaceuticals LLC
$40
AbbVie, Inc.
$39
Avion Pharmaceuticals
$39
Mallinckrodt LLC
$30
Celgene Corporation
$28
IMPEL PHARMACEUTICALS INC.
$23
AQUESTIVE THERAPEUTICS, INC.
$21
Neurelis, Inc.
$21
CSL Behring
$20
Life Molecular Imaging Ltd
$16
Almatica Pharma LLC
$16
Octapharma USA, Inc.
$15
Vertical Pharmaceuticals, LLC
$15
Egalet US Inc
$15
ARBOR PHARMACEUTICALS, INC.
$14
Top 3 companies account for 59.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Actemra · Aimovig · BOTOX · Briviact · COMIRNATY · CONTRAVE · CREXONT · DUEXIS · DUOPA · DaTscan · Dhivy · Duopa · EMGALITY · ETERNA · Epidiolex · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA Xsail · OSMOLEX ER · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · SYMPAZAN · Soliris · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · Utibron · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WATCHMAN · XARELTO · Xadago · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Aventura?
Compare neurologists in the Aventura area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
297
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schwartzbard is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schwartzbard experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Schwartzbard performed 206 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Schwartzbard receive payments from pharmaceutical companies?
Yes. Dr. Schwartzbard received a total of $472,713 from 66 companies across 1,187 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwartzbard's costs compare to other neurologists in Aventura?
Dr. Schwartzbard's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwartzbard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →